Both Insulin Resistance and Diabetes in Psammomys obesus Upregulate the Hepatic Machinery Involved in Intracellular VLDL Assembly

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 24, Issue 1, 2004, Pages 118-123

  Zoltowska, M ^a,b   Ziv, E ^c   Delvin, E ^a,b   Lambert, M ^a,b   Seidman, E ^a,b   Levy, E ^a,b  

^a UNIVERSITY OF MONTREAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

apo B degradation; Diabetes; Insulin resistance; Microsomal triglyceride transfer protein; VLDL production

Indexed keywords

ACYLGLYCEROL PALMITOYLTRANSFERASE; APOLIPOPROTEIN B; DIACYLGLYCEROL ACYLTRANSFERASE; FATTY ACID; PROTEASOME INHIBITOR; TRIACYLGLYCEROL; TYLOXAPOL; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FATTY ACID BLOOD LEVEL; HYPERCHOLESTEROLEMIA; HYPERINSULINEMIA; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; LIPOGENESIS; LIPOPROTEIN SECRETION; LIVER CELL; LIVER MICROSOME; NONHUMAN; PRIORITY JOURNAL; PROTEIN TRANSPORT; PSAMMOMYS OBESUS; UPREGULATION; WEIGHT GAIN;

ACETYLCYSTEINE; ANIMALS; APOLIPOPROTEINS B; CELLS, CULTURED; CYSTEINE ENDOPEPTIDASES; DIABETES MELLITUS; DISEASE MODELS, ANIMAL; GERBILLINAE; HEPATOCYTES; HYPERCHOLESTEROLEMIA; HYPERINSULINISM; HYPERTRIGLYCERIDEMIA; INSULIN; INSULIN RESISTANCE; LEUPEPTINS; LIPOPROTEINS, VLDL; LIVER; MULTIENZYME COMPLEXES; PROTEASE INHIBITORS; PROTEASOME ENDOPEPTIDASE COMPLEX;

EID: 0346492596     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000105901.18785.99     Document Type: Article

References (31)

1. Seidell JC. Obesity, insulin resistance and diabetes: a worldwide epidemic. Br J Nutr. 2000;83(suppl 1):S5-S8.
2. DeFronzo RA. Lilly lecture 1987: the triumvirate: beta-cell, muscle, liver: a collusion responsible for NIDDM. Diabetes. 1988;37:667-687.
3. Moller DE, ed. Insulin Resistance. London, England: John Wiley & Sons; 1993:143-186.
4. Malmstrom R, Packard CJ, Caslake M, Bedford D, Stewart P, Yki-Jarvinen H, Shepherd J, Taskinen MR. Defective regulation of triglyceride metabolism by insulin in the liver in NIDDM. Diabetologia. 1997;40:454-462.
5. Roden M, Price TB, Perseghin G, Petersen KF, Rothman DL, Cline GW, Shulman GI. Mechanism of free fatty acid-induced insulin resistance in humans. J Clin Invest. 1996;97:2859-2865.
6. Walder KR, Fahey RP, Morton GJ, Zimmet PZ, Collier GR. Character-ization of obesity phenotypes in Psammomys obesus (Israeli sand rats). Int J Exp Diabetes Res. 2000;1:177-184.
7. Shafrir E, Ziv E. Cellular mechanism of nutritionally induced insulin resistance: the desert rodent Psammomys obesus and other animals in which insulin resistance leads to detrimental outcome. J Basic Clin Physiol Pharmacol. 1998;9:347-385.
8. Joffe B, Zimmet P. The thrifty genotype in type 2 diabetes: an unfinished symphony moving to its finale? Endocrine. 1998;9:139-141.
9. Swinburn BA, Boyce VL, Bergman RN, Howard BV, Bogardus C. Deterioration in carbohydrate metabolism and lipoprotein changes induced by modern, high fat diet in Pima Indians and Caucasians. J Clin Endocrinol Metab. 1991;73:156-165.
10. O'Dea K, Traianedes K, Hopper JL, Larkins RG. Impaired glucose tolerance, hyperinsulinemia, and hypertriglyceridemia in Australian aborigines from the desert. Diabetes Care. 1988;11:23-29.
11. Havel RJ, Kane JP. Introduction: structure and metabolism of plasma lipoproteins and disorders of the biogenesis and secretion of lipoproteins containing the B apolipoproteins. In: Scriver CE, Beaudet AL, Sly WE, Valle D, eds. The Metabolic and Molecular Bases of Inherited Disease. New York, NY: McGraw-Hill; 1995:1841-1885.
12. Teng B, Burant CF, Davidson NO. Molecular cloning of an apolipoprotein B messenger RNA editing protein. Science. 1993;260:1816-1819.
13. Hodges PE, Navaratnam N, Greeve JC, Scott J. Site-specific creation of uridine from cytidine in apolipoprotein B mRNA editing. Nucleic Acids Res. 1991;19:1197-1201.
14. Smith HC, Kuo SR, Backus JW, Harris SG, Sparks CE, Sparks JD. In vitro apolipoprotein B mRNA editing: identification of a 27S editing complex. Proc Natl Acad Sci U S A. 1991;88:1489-1493.
15. Bostrom K, Boren J, Wettesten M, Sjoberg A, Bondjers G, Wiklund O, Carlsson P, Olofsson SO. Studies on the assembly of apo B-100-containing lipoproteins in HepG2 cells. J Biol Chem. 1988;263:4434-4442.
16. Pullinger CR, North JD, Teng BB, Rifici VA, Ronhild de Brito AE, Scott J. The apolipoprotein B gene is constitutively expressed in HepG2 cells: regulation of secretion by oleic acid, albumin, and insulin, and measurement of the mRNA half-life. J Lipid Res. 1989;30:1065-1077.
17. Borchardt RA, Davis RA. Intrahepatic assembly of very low density lipoproteins: rate of transport out of the endoplasmic reticulum determines rate of secretion. J Biol Chem. 1987;262:16394-16402.
18. Phung TL, Roncone A, Jensen KL, Sparks CE, Sparks JD. Phosphoinositide 3-kinase activity is necessary for insulin-dependent inhibition of apolipoprotein B secretion by rat hepatocytes and localizes to the endoplasmic reticulum. J Biol Chem. 1997;272:30693-30702.
19. Zoltowska M, Ziv E, Delvin E, Stan S, Bar-On H, Kalman R, Levy E. Circulating lipoproteins and hepatic sterol metabolism in Psammomys obesus prone to obesity, hyperglycemia and hyperinsulinemia. Atherosclerosis. 2001;157:85-96.
20. Kalman R, Adler JH, Lazarovici G, Bar-On H, Ziv E. The efficiency of sand rat metabolism is responsible for development of obesity and diabetes. J Basic Clin Physiol Pharmacol. 1993;4:57-68.
21. Li X, Catalina F, Grundy SM, Patel S. Method to measure apolipoprotein B-48 and B-100 secretion rates in an individual mouse: evidence for a very rapid tumover of VLDL and preferential removal of B-48-relative to B-100-containing lipoproteins. J Lipid Res. 1996;37:210-220.
22. Haidari M, Leung N, Mahbub F, Uffelman KD, Kohen-Avramoglu R, Lewis GF, Adeli K. Fasting and postprandial overproduction of intestinally derived lipoproteins in an animal model of insulin resistance: evidence that chronic fructose feeding in the hamster is accompanied by enhanced intestinal de novo lipogenesis and ApoB48-containing lipoprotein overproduction. J Biol Chem. 2002;277:31646-31655.
23. Mitchell DM, Zhou M, Pariyarath R, Wang H, Aitchison JD, Ginsberg HN, Fisher EA. Apoprotein B100 has a prolonged interaction with the translocon during which its lipidation and translocation change from dependence on the microsomal triglyceride transfer protein to independence. Proc Nati Acad Sci U S A. 1998;95:14733-14738.
24. Wetterau JR, Aggerbeck LP, Bouma ME, Eisenberg C, Munck A, Hermier M, Schmitz J, Gay G, Rader DJ, Gregg RE. Absence of microsomal triglyceride transfer protein in individuals with abetalipoproteinemia. Science. 1992;258:999-1001.
25. Raabe M, Flynn LM, Zlot CH, Wong JS, Veniant MM, Hamilton RL, Young SG. Knockout of the abetalipoproteinemia gene in mice: reduced lipoprotein secretion in heterozygotes and embryonic lethality in homozygotes. Proc Nati Acad Sci U S A. 1998;95:8686-8691.
26. Tietge UJ, Bakillah A, Maugeais C, Tsukamoto K, Hussain M, Rader DJ. Hepatic overexpression of microsomal triglyceride transfer protein (MTP) results in increased in vivo secretion of VLDL triglycerides and apolipoprotein B. J Lipid Res. 1999;40:2134-2139.
27. Bartels ED, Lauritsen M, Nielsen LB. Hepatic expression of microsomal triglyceride transfer protein and in vivo secretion of triglyceride-rich lipoproteins are increased in obese diabetic mice. Diabetes. 2002;51:1233-1239.
28. Taghibiglou C, Carpentier A, Van Iderstine SC, Chen B, Rudy D, Aiton A, Lewis GF, Adeli K. Mechanisms of hepatic very low density lipoprotein overproduction in insulin resistance: evidence for enhanced lipoprotein assembly, reduced intracellular ApoB degradation, and increased microsomal triglyceride transfer protein in a fructose-fed hamster model. J Biol Chem. 2000;275:8416-8425.
29. Sato R, Miyamoto W, Inoue J, Terada T, Imanaka T, Maeda M. Sterol regulatory element-binding protein negatively regulates microsomal triglyceride transfer protein gene transcription. J Biol Chem. 1999;274:24714-24720.
30. Lehner R, Kuksis A. Biosynthesis of triacylglycerols. Prog Lipid Res. 1996;35:169-201.
31. Chen HC, Smith SJ, Ladha Z, Jensen DR, Ferreira LD, Pulawa LK, McGuire JG, Pitas RE, Eckel RH, Farese RV Jr. Increased insulin and leptin sensitivity in mice lacking acyl CoA:diacylglycerol acytlransferase 1. J Clin Invest. 2002;109:1049-1055.